Correction: Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy’s skin toxicity in breast radiotherapy

Frontiers in Oncology 2026 Open access

Read full text
Authors: Jiao Xue, Wenjun Zhao, Chenchen Wu
DOI: 10.3389/fonc.2026.1796339
Cited by: 0

Abstract

Correction on: Xue J, Zhao W, Wu C. Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy's skin toxicity in breast radiotherapy. Front Oncol (2026Oncol ( ) 16:1760716. doi: 10.3389/fonc.2026.1760716 .1760716 There was a mistake in the captions of Figure 1 and Figure 3 as published. The captions for Figure 1 and Figure 3 were erroneously swapped. The corrected captions of Figure 1 The original version of this article has been updated.End of template. If you would like to request a correction for a reason not seen here, please contact the

Fields of Study & Subjects

Advanced Radiotherapy Techniques Radiation Therapy and Dosimetry Breast Cancer Treatment Studies

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1796339–1796339
Publication date
11 February 2026
Language
EN